The impending loss of exclusivity for Eliquis (apixaban) is poised to become one of the most significant revenue-generating events in…
Read More
Pharma and Medtech Giants Navigate Shifting Landscapes in Q1 Earnings Season
The first quarter of 2024 has concluded, leaving a landscape reshaped by evolving market dynamics, groundbreaking therapeutic advancements, and persistent…
Read More
Global Healthcare Giants Unite: GHO Capital and CBC Group Forge Largest Dedicated Investment Manager with $21 Billion AUM
Two prominent forces in specialized healthcare investment, Global Healthcare Opportunities (GHO) and CBC Group, have announced a groundbreaking merger to…
Read More
The Epoch of Giants: Unraveling the Mystery of Earth’s Colossal Insects
Three hundred million years ago, Earth was a planet transformed, a realm of geological upheaval and biological extravagance. The continents,…
Read More
The Reign of Giants: New Study Questions Oxygen’s Role in Prehistoric Insect Gigantism
Three hundred million years ago, Earth was a planet dramatically different from the one we inhabit today. Continents were not…
Read More
Earth’s Ancient Giants: New Study Challenges Oxygen Theory Behind Prehistoric Insect Colossi
Three hundred million years ago, Earth was a planet vastly different from the one we inhabit today. Its landmasses were…
Read More
US Import Tariffs Fail to Deter Biopharma Giants as European Contract Manufacturing Surges for FDA-Approved Drugs
The biopharmaceutical industry is demonstrating a significant and counterintuitive trend in 2025, with companies increasingly channeling investments into European-based contract…
Read More
